Estonia vs Sweden: Treatment success rate for patients treated for MDR-TB
Estonia
88.0%
in 2022
Sweden
87.0%
in 2022
Estonia rank
26th
Sweden rank
27th
Treatment success rate for patients treated for MDR-TB over time
- Estonia
- Sweden
How they compare
Estonia currently reports 88.0% against 87.0% in Sweden, a difference of 1.0%.
The two have swapped places 3 times across 16 shared years of data; in 2007 it was Sweden ahead.
Estonia ranks 26th and Sweden ranks 27th of 163 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Estonia | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.0% | 85.3% | 39.3% | Sweden |
| 2010s | 71.6% | 89.0% | 17.4% | Sweden |
| 2020s | 85.3% | 90.0% | 4.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Estonia or Sweden?
- Estonia, at 88.0% against 87.0% in Sweden as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Estonia and Sweden?
- 1.0%, with Estonia ahead.
- How many years of comparable data are there for Estonia and Sweden?
- 16 years are reported by both, from 2007 to 2022.
- How do Estonia and Sweden rank globally for treatment success rate for patients treated for mdr-tb?
- Estonia ranks 26th and Sweden ranks 27th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.